NCT01842503View on ClinicalTrials.gov

Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Alcohol Dependence
Interventions
DRUG

GET 73

300 mg tid on 3 days cycle

DRUG

inactive ingredients capsule

3 capsules tid on 3 days cycle

Trial Locations (1)

02908

Roger Williams Medical Center, Providence

Sponsors

Collaborators (1)

Quotient Bioresearch
All Listed Sponsors
collaborator

Voisin Consulting, Inc.

INDUSTRY

collaborator

Latis S.r.l.

INDUSTRY

collaborator

Quotient Bioresearch

INDUSTRY

lead

Laboratorio Farmaceutico Ct S.r.l.

INDUSTRY